You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Bracco Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Bracco
International Patents:34
US Patents:3
Tradenames:64
Ingredients:32
NDAs:40

Drugs and US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ISOVUE-200 iopamidol INJECTABLE;INJECTION 018735-006 Jul 7, 1987 AP2 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Bracco VARIBAR NECTAR barium sulfate SUSPENSION;ORAL 208143-004 Jul 7, 2017 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Bracco CHROMITOPE SODIUM sodium chromate cr-51 INJECTABLE;INJECTION 013993-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco ISOVUE-300 iopamidol INJECTABLE;INJECTION 018735-002 Dec 31, 1985 4,001,323 ⤷  Try a Trial
Bracco KINEVAC sincalide INJECTABLE;INJECTION 017697-001 Approved Prior to Jan 1, 1982 6,803,046 ⤷  Try a Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-003 Nov 23, 2004 4,916,246 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Bracco Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands ⤷  Try a Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
1556389 92943 Luxembourg ⤷  Try a Trial PRODUCT NAME: CEFTOLOZANE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, EN PARTICULIER UN SEL D'ACIDE SULFURIQUE (ZERBAXA); FIRST REGISTRATION: 20150922
1856135 CA 2020 00018 Denmark ⤷  Try a Trial PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.